Prostatic artery embolization(PAE) is a minimally invasive operation for the treatment of prostatic hyperplasia and hypertrophy, which can significantly improve urination symptoms and improve the quality of life of patients.The operation is interventional therapy, which is to place the microcatheter in the small prostate artery, block the prostate artery, make the enlarged prostate tissue ischemia, and then atrophy, so as to reduce the size of the prostate, improve urination symptoms.
This report contains market size and forecasts of Prostatic Arterial Embolization (PAE) in Global, including the following market information:
Global Prostatic Arterial Embolization (PAE) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostatic Arterial Embolization (PAE) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Guidewires Implantation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostatic Arterial Embolization (PAE) include Merit Medical Systems, Boston Scientific, Mentice, Siemens Healthineers, Terumo and General Electric, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostatic Arterial Embolization (PAE) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostatic Arterial Embolization (PAE) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostatic Arterial Embolization (PAE) Market Segment Percentages, by Type, 2021 (%)
Guidewires Implantation
Micro Catheters Implantation
Microspheres Implantation
Global Prostatic Arterial Embolization (PAE) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostatic Arterial Embolization (PAE) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Prostatic Arterial Embolization (PAE) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostatic Arterial Embolization (PAE) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostatic Arterial Embolization (PAE) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostatic Arterial Embolization (PAE) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merit Medical Systems
Boston Scientific
Mentice
Siemens Healthineers
Terumo
General Electric